No results for ‘’
Chemfab Alkalis Ltd
NSE: CHEMFAB BSE: 541269
₹379.70
(0.92%)
Thu, 20 Aug 2026, 05:13 pm
Market Cap (in Cr)544.76
PE Ratio0
Dividend0.33
- Overview
- Analysis
- Financials
- Ratios
- shareholding
- Technical Analysis
- Corporate Actions
- Peer Comparison
- About
- Company History
- Deals
- News
Chemfab Alkalis Analysis
dividend
Pros
- Dividends paid are thoroughly covered by earnings (14.6x coverage).
- Chemfab Alkalis's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
Cons
- Chemfab Alkalis has only been paying a dividend for 2 years, and since then there has been no growth.
- Whilst dividend payments have been stable, Chemfab Alkalis has been paying a dividend for less than 10 years.
- Chemfab Alkalis's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
Pros
- Chemfab Alkalis is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Chemfab Alkalis is profitable, therefore cash runway is not a concern.
- Chemfab Alkalis is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (150.8%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 1.4x debt.
- Chemfab Alkalis's cash and other short term assets cover its long term commitments.
- Interest payments on debt are well covered by earnings (EBIT is 9.5x coverage).
- Chemfab Alkalis's level of debt (13.1%) compared to net worth is satisfactory (less than 40%).
Cons
- High level of physical assets or inventory.
management
Pros
- The tenure for the Chemfab Alkalis board of directors is about average.
Cons
- The average tenure for the Chemfab Alkalis management team is less than 2 years, this suggests a new team.
misc
Pros
Cons
- Chemfab Alkalis is not covered by any analysts.
- Chemfab Alkalis has significant price volatility in the past 3 months.
past
Pros
- Chemfab Alkalis's 1-year earnings growth exceeds its 5-year average (51.8% vs 27.6%)
- Chemfab Alkalis has delivered over 20% year on year earnings growth in the past 5 years.
- Chemfab Alkalis used its assets more efficiently than the IN Chemicals industry average last year based on Return on Assets.
- Chemfab Alkalis has significantly improved its use of capital last year versus 3 years ago (Return on Capital Employed).
- Chemfab Alkalis's earnings growth has exceeded the IN Chemicals industry average in the past year (51.8% vs 9.1%).
Cons
- Chemfab Alkalis has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
value
Pros
- Chemfab Alkalis's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Chemfab Alkalis is good value based on assets compared to the IN Chemicals industry average.
- Chemfab Alkalis is good value based on earnings compared to the IN Chemicals industry average.
- Chemfab Alkalis is good value based on earnings compared to the India market.
Cons
- Chemfab Alkalis's share price is below the future cash flow value, but not at a substantial discount (< 40%).
- CHEMFAB underperformed the Chemicals industry which returned 2.2% over the past year.
- CHEMFAB underperformed the Market in India which returned -14.5% over the past year.
- NSEI:CHEMFAB is up 5.2% underperforming the Chemicals industry which returned 6.9% over the past month.
- NSEI:CHEMFAB is up 5.2% underperforming the market in India which returned 8% over the past month.